Insider Transactions in Q3 2022 at Allovir, Inc. (ALVR)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2022
|
David Hallal |
SELL
Open market or private sale
|
Indirect |
400,000
-35.68%
|
$2,800,000
$7.35 P/Share
|
|
Sep 02
2022
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
493
-0.12%
|
$3,451
$7.89 P/Share
|
|
Aug 18
2022
|
Diana Brainard Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,564
-0.71%
|
$31,948
$7.76 P/Share
|
|
Aug 16
2022
|
Ann M. Leen Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+25.86%
|
-
|
|
Aug 16
2022
|
Vikas Sinha |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+8.79%
|
-
|
|
Aug 16
2022
|
Edward Miller General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+5.66%
|
-
|
|
Aug 16
2022
|
Diana Brainard Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+13.48%
|
-
|
|
Aug 16
2022
|
Jeroen B Van Beek Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+3.6%
|
-
|
|
Aug 16
2022
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
15,590
-3.88%
|
$124,720
$8.3 P/Share
|
|
Aug 16
2022
|
Brett R Hagen Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+14.97%
|
-
|
|
Jul 28
2022
|
Vikas Sinha |
BUY
Grant, award, or other acquisition
|
Indirect |
3,253,796
+16.33%
|
$13,015,184
$4.61 P/Share
|
|
Jul 28
2022
|
David Hallal |
BUY
Grant, award, or other acquisition
|
Indirect |
3,253,796
+16.33%
|
$13,015,184
$4.61 P/Share
|
|
Jul 28
2022
|
Morana Jovan Embiricos |
BUY
Grant, award, or other acquisition
|
Indirect |
8,152,247
+32.23%
|
$32,608,988
$4.61 P/Share
|
|
Jul 28
2022
|
Elevate Bio, LLC Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,253,796
+16.33%
|
$13,015,184
$4.61 P/Share
|
|
Jul 28
2022
|
Ansbert Gadicke Director |
BUY
Grant, award, or other acquisition
|
Indirect |
3,253,796
+16.33%
|
$13,015,184
$4.61 P/Share
|
|
Jul 21
2022
|
Ercem Atillasoy Officer |
SELL
Open market or private sale
|
Direct |
1,533
-1.14%
|
$7,665
$5.38 P/Share
|
|
Jul 21
2022
|
David Hallal |
SELL
Open market or private sale
|
Direct |
4,227
-0.2%
|
$21,135
$5.33 P/Share
|
|
Jul 20
2022
|
Vikas Sinha |
SELL
Open market or private sale
|
Direct |
1,432
-0.15%
|
$7,160
$5.21 P/Share
|
|
Jul 20
2022
|
Ercem Atillasoy Officer |
SELL
Open market or private sale
|
Direct |
563
-0.42%
|
$2,815
$5.21 P/Share
|
|
Jul 20
2022
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,058
-0.26%
|
$5,290
$5.21 P/Share
|
|
Jul 01
2022
|
Ann M. Leen Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+17.66%
|
-
|
|
Jul 01
2022
|
Brett R Hagen Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,500
+10.09%
|
-
|
|
Jul 01
2022
|
Edward Miller General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+5.62%
|
-
|
|
Jul 01
2022
|
Vikas Sinha |
BUY
Grant, award, or other acquisition
|
Direct |
29,400
+3.03%
|
-
|
|
Jul 01
2022
|
Ercem Atillasoy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+9.36%
|
-
|
|
Jul 01
2022
|
Diana Brainard Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,125
+8.15%
|
-
|
|
Jul 01
2022
|
Jeroen B Van Beek Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+3.36%
|
-
|